Should Canada Strengthen IP Protection for Pharmaceutical Products? The European Union Thinks So...

The Canadian government and European Union (EU) are currently negotiating a Comprehensive Economic and Trade Agreement (CETA).  A key issue has been ensuring that Canadian intellectual property rights for pharmaceutical products are brought in line with EU standards.  It appears that the EU believes Canada’s legal regime regulating the approval of drugs does not provide […]